NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 25 min 39 sec ago

Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)

Wed, 2024-02-28 11:06
Funding Opportunity PAR-24-108 from the NIH Guide for Grants and Contracts. The purpose of the NINDS Institutional Translational Research Training Program is to equip trainees with the knowledge and skills needed to advance basic research toward clinical application. These programs will support, students and/or postdocs conducting basic, disease-relevant research in an environment that includes 1) basic neuroscientists and clinicians who are actively engaged in collaborative research projects, 2) neuroscience researchers with expertise in translational processes who are conducting research designed to move basic discoveries toward clinical application and 3) relationships with industry and government regulatory agencies. Programs will have a cohesive educational approach to translational training in areas relevant to the NINDS mission, and in which students and postdocs learn the processes involved in translational research in the context of their individual projects. Programs supported by this FOA must include activities that ensure a thorough understanding of experimental design, strong statistical and analytical skills, and skills for communicating science with a wide variety of audiences. These programs are intended to be 2 years in duration and support training of one or more of the following groups: advanced predoctoral students, postdoctoral fellows and fellowship-stage clinicians. Upon completion of the program, trainees will be prepared to address basic research problems with an understanding of the requirements for translating discoveries into viable therapies.

Notice of Correction of Expiration Date in PAR-21-166 and NOT-CA-24-025

Wed, 2024-02-28 10:11
Notice NOT-CA-24-036 from the NIH Guide for Grants and Contracts

Phase-out and Termination of NICHD Participation in the NIH MERIT (R37) Program

Wed, 2024-02-28 09:38
Notice NOT-HD-24-013 from the NIH Guide for Grants and Contracts

Update Related to the Issuance of the FY 2024 NIH Grants Policy Statement

Wed, 2024-02-28 09:33
Notice NOT-OD-24-069 from the NIH Guide for Grants and Contracts

Notice of Change to Application Due Date for PAR-21-208, "Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)"

Wed, 2024-02-28 03:24
Notice NOT-DA-23-062 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Mechanisms of Osteoarthritis

Wed, 2024-02-28 02:41
Notice NOT-AG-24-002 from the NIH Guide for Grants and Contracts

Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)

Wed, 2024-02-28 02:08
Funding Opportunity PAR-24-157 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications from Small Business Concerns (SBCs) to pursue the development of improved clinical diagnostics or the development of alternative clinical diagnostics that address health disparities created by clinical laboratory assays and/or point-of-care devices that fail to incorporate diverse patient groups. Applicants will identify a potential issue within a clinical diagnostic or group of clinical diagnostics that perpetuates health inequity and disparities, clearly define the disparity issue, and develop a solution to address the concern.

Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)

Wed, 2024-02-28 01:48
Funding Opportunity PAR-24-158 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications from Small Business Concerns (SBCs) to pursue the development of improved clinical diagnostics or the development of alternative clinical diagnostics that address health disparities created by clinical laboratory assays and/or point-of-care devices that fail to incorporate diverse patient groups. Applicants will identify a potential issue within a clinical diagnostic or group of clinical diagnostics that perpetuates health inequity and disparities, clearly define the disparity issue, and develop a solution to address the concern.

Notice of Change to NINDS' Policy on Special Council Review of Research Applications

Wed, 2024-02-28 01:29
Notice NOT-NS-24-060 from the NIH Guide for Grants and Contracts

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

Tue, 2024-02-27 09:46
Funding Opportunity PAR-24-119 from the NIH Guide for Grants and Contracts. The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.

Notice of Early Expiration of PAR-23-118 "National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed)"

Tue, 2024-02-27 09:35
Notice NOT-GM-24-024 from the NIH Guide for Grants and Contracts

Pages